pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
CRO/CDMO · news · pharmadog
← back to CRO/CDMO
News · CRO/CDMO
102
stories
Sep 2, 26
Fortrea boosts early-phase CRO platform with $45M acquisition of Worldwide division
fiercebiotech
Aug 28, 26
Multispecifics are transforming the CDMO development architecture
biospace
Aug 28, 26
CAR T for autoimmune disease benefits from oncology’s lessons—and will deliver its own
biospace
Aug 27, 26
What’s in Merck and Moderna’s cancer vaccine algorithm?
stat
Aug 27, 26
RayzeBio's $173M radiopharma plan; Lonza creates commercial chief position
endpoints
Aug 26, 26
BMS ends Cellares pact over cell therapy production problems, triggering layoffs
biospace
Aug 26, 26
Beyond the Bandwidth Ceiling: Redesigning Advanced Therapy Operating Models for the Digital Staff Era
fiercebiotech
Aug 26, 26
CDMO hiring tough as demand for specialized talent outpaces supply
biospace
Aug 26, 26
Inside the Gulf biotech deal model, ahead of RGMBS 2026 in Riyadh
biospace
Aug 25, 26
McKesson strikes $2.25B deal to snap up Precision Medicine Group
fiercebiotech
Aug 24, 26
Spruce’s successful FDA talks plant seeds for Q4 filing of ultra-rare disease drug
fiercebiotech
Aug 20, 26
WuXi Bio to offload chromatography unit; Cabaletta names another CDMO partner
endpoints
Aug 20, 26
Medigen links up with Charles River in push to take enterovirus vaccine global
fiercebiotech
Aug 20, 26
7 biopharma M&A deals where layoffs followed
biospace
Aug 19, 26
Merck and Sarah Cannon team up to boost oncology trial efficiency
fiercebiotech
Aug 19, 26
Developing a Global Clinical Trial Strategy for Emerging Biotechs
fiercebiotech
Aug 18, 26
Rebounding biotech funds expected to spur CDMO growth within year
biospace
Aug 17, 26
Baylor Genetics hit by cybersecurity attack targeting patient, staff information
fiercebiotech
Aug 14, 26
After 2 undisclosed gene therapy deaths, can China’s alternative regulatory path still be trusted?
fiercebiotech
Aug 13, 26
Chutes & Ladders—Former Legend CEO lands at K2
fiercebiotech
Aug 13, 26
July's biopharma layoffs affect 466 employees, a 94% year-over-year drop
biospace
Aug 12, 26
AI clinical monitoring agent can deliver up to 82 times the ROI in oncology: report
fiercebiotech
Aug 11, 26
CytoDyn’s leronlimab reaffirms HIV potential after combo treatment eradicates virus in infant macaques
fiercebiotech
Aug 11, 26
Scholar Rock rejigs approval filing after FDA flags violations at Novo plant
biospace
Aug 11, 26
IRBs have a problem. Can North Star’s nonprofit model save it?
stat
Aug 10, 26
Judge blocks enforcement of WuXi AppTec's designation as Chinese military company
endpoints
Aug 10, 26
Scholar Rock ditches Novo’s legacy Catalent plant in FDA refiling of SMA drug
fiercebiotech
Aug 7, 26
2026 Q2 Job Market Report: Job postings keep rising as fewer companies cut employees
biospace
Aug 6, 26
Vedanta gets $60M to finish Phase 3 for C. diff microbiome therapy
endpoints
Aug 6, 26
CROs vs. biotechs: Finding the right fit
biospace
← prev
page 2 of 4
next →
